223 related articles for article (PubMed ID: 29706533)
21. Conformational states of Ras complexed with the GTP analogue GppNHp or GppCH2p: implications for the interaction with effector proteins.
Spoerner M; Nuehs A; Ganser P; Herrmann C; Wittinghofer A; Kalbitzer HR
Biochemistry; 2005 Feb; 44(6):2225-36. PubMed ID: 15697248
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of guanosine triphosphate hydrolysis by Ras and Ras-GAP proteins as rationalized by ab initio QM/MM simulations.
Grigorenko BL; Nemukhin AV; Shadrina MS; Topol IA; Burt SK
Proteins; 2007 Feb; 66(2):456-66. PubMed ID: 17094109
[TBL] [Abstract][Full Text] [Related]
23. Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site.
Mazhab-Jafari MT; Marshall CB; Smith MJ; Gasmi-Seabrook GM; Stathopulos PB; Inagaki F; Kay LE; Neel BG; Ikura M
Proc Natl Acad Sci U S A; 2015 May; 112(21):6625-30. PubMed ID: 25941399
[TBL] [Abstract][Full Text] [Related]
24. Guanine-nucleotide binding activity, interaction with GTPase-activating protein and solution conformation of the human c-Ha-Ras protein catalytic domain are retained upon deletion of C-terminal 18 amino acid residues.
Fujita-Yoshigaki J; Ito Y; Yamasaki K; Muto Y; Miyazawa T; Nishimura S; Yokoyama S
J Protein Chem; 1992 Dec; 11(6):731-9. PubMed ID: 1466766
[TBL] [Abstract][Full Text] [Related]
25. Dynamic polymorphism of Ras observed by single molecule FRET is the basis for molecular recognition.
Arai Y; Iwane AH; Wazawa T; Yokota H; Ishii Y; Kataoka T; Yanagida T
Biochem Biophys Res Commun; 2006 May; 343(3):809-15. PubMed ID: 16564025
[TBL] [Abstract][Full Text] [Related]
26. NMR
Sharma AK; Lee SJ; Zhou M; Rigby AC; Townson SA
Biomol NMR Assign; 2019 Apr; 13(1):227-231. PubMed ID: 30798456
[TBL] [Abstract][Full Text] [Related]
27. Dissection of the GTPase mechanism of Ras protein by MD analysis of Ras mutants.
Friedman ZY; Devary Y
Proteins; 2005 May; 59(3):528-33. PubMed ID: 15789417
[TBL] [Abstract][Full Text] [Related]
28. The higher level of complexity of K-Ras4B activation at the membrane.
Jang H; Banerjee A; Chavan TS; Lu S; Zhang J; Gaponenko V; Nussinov R
FASEB J; 2016 Apr; 30(4):1643-55. PubMed ID: 26718888
[TBL] [Abstract][Full Text] [Related]
29. Crystal structures at 2.2 A resolution of the catalytic domains of normal ras protein and an oncogenic mutant complexed with GDP.
Tong LA; de Vos AM; Milburn MV; Kim SH
J Mol Biol; 1991 Feb; 217(3):503-16. PubMed ID: 1899707
[TBL] [Abstract][Full Text] [Related]
30. Three-dimensional structure of p21H-ras and its implications.
Wittinghofer F
Semin Cancer Biol; 1992 Aug; 3(4):189-98. PubMed ID: 1421163
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic G12D mutation alters local conformations and dynamics of K-Ras.
Vatansever S; Erman B; Gümüş ZH
Sci Rep; 2019 Aug; 9(1):11730. PubMed ID: 31409810
[TBL] [Abstract][Full Text] [Related]
32. New insight into the dynamic properties and the active site architecture of H-Ras p21 revealed by X-ray crystallography at very high resolution.
Klink BU; Scheidig AJ
BMC Struct Biol; 2010 Oct; 10():38. PubMed ID: 20973973
[TBL] [Abstract][Full Text] [Related]
33. Revisiting the structural flexibility of the complex p21(ras)-GTP: the catalytic conformation of the molecular switch II.
Soares TA; Miller JH; Straatsma TP
Proteins; 2001 Dec; 45(4):297-312. PubMed ID: 11746677
[TBL] [Abstract][Full Text] [Related]
34. The Structural Basis of Oncogenic Mutations G12, G13 and Q61 in Small GTPase K-Ras4B.
Lu S; Jang H; Nussinov R; Zhang J
Sci Rep; 2016 Feb; 6():21949. PubMed ID: 26902995
[TBL] [Abstract][Full Text] [Related]
35. Revealing the mechanism of action of a first-in-class covalent inhibitor of KRASG12C (ON) and other functional properties of oncogenic KRAS by
Sharma AK; Pei J; Yang Y; Dyba M; Smith B; Rabara D; Larsen EK; Lightstone FC; Esposito D; Stephen AG; Wang B; Beltran PJ; Wallace E; Nissley DV; McCormick F; Maciag AE
J Biol Chem; 2024 Feb; 300(2):105650. PubMed ID: 38237681
[TBL] [Abstract][Full Text] [Related]
36. Solution structure of the state 1 conformer of GTP-bound H-Ras protein and distinct dynamic properties between the state 1 and state 2 conformers.
Araki M; Shima F; Yoshikawa Y; Muraoka S; Ijiri Y; Nagahara Y; Shirono T; Kataoka T; Tamura A
J Biol Chem; 2011 Nov; 286(45):39644-53. PubMed ID: 21930707
[TBL] [Abstract][Full Text] [Related]
37. Mapping the nucleotide-dependent conformational change of human N-ras p21 in solution by heteronuclear-edited proton-observed NMR methods.
Hu JS; Redfield AG
Biochemistry; 1993 Jul; 32(26):6763-72. PubMed ID: 8329399
[TBL] [Abstract][Full Text] [Related]
38. Structural effects of the binding of GTP to the wild-type and oncogenic forms of the ras-gene-encoded p21 proteins.
Monaco R; Chen JM; Friedman FK; Brandt-Rauf P; Chung D; Pincus MR
J Protein Chem; 1995 Nov; 14(8):721-9. PubMed ID: 8747433
[TBL] [Abstract][Full Text] [Related]
39. Molecular Basis for Allosteric Inhibition of GTP-Bound H-Ras Protein by a Small-Molecule Compound Carrying a Naphthalene Ring.
Matsumoto S; Hiraga T; Hayashi Y; Yoshikawa Y; Tsuda C; Araki M; Neya M; Shima F; Kataoka T
Biochemistry; 2018 Sep; 57(36):5350-5358. PubMed ID: 30141910
[TBL] [Abstract][Full Text] [Related]
40. Dynamic studies of H-Ras•GTPγS interactions with nucleotide exchange factor Sos reveal a transient ternary complex formation in solution.
Vo U; Vajpai N; Embrey KJ; Golovanov AP
Sci Rep; 2016 Jul; 6():29706. PubMed ID: 27412770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
